Cytosorbents Corp Net Income Loss

• Cytosorbents Corp showed an increase of +60.4% in Net Income Loss from 2024 to 2025.
• This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 19 years of available data (2007 to 2025), Cytosorbents Corp's Net Income Loss has declined by 144.7%.
• Historical annual values: Fiscal year 2025: -$8.20 million | Fiscal year 2024: -$20.72 million | Fiscal year 2023: -$29.25 million | Fiscal year 2022: -$32.81 million | Fiscal year 2021: -$24.56 million | Fiscal year 2020: -$7.84 million | Fiscal year 2019: -$19.27 million | Fiscal year 2018: -$17.21 million | Fiscal year 2017: -$8.46 million | Fiscal year 2016: -$11.76 million | Fiscal year 2015: -$9.48 million | Fiscal year 2014: -$9.32 million | Fiscal year 2013: -$4.68 million | Fiscal year 2012: -$3.66 million | Fiscal year 2011: -$5.48 million | Fiscal year 2010: -$2.91 million | Fiscal year 2009: -$2.74 million | Fiscal year 2008: -$3.02 million | Fiscal year 2007: -$3.35 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026